Research, PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eur J Cancer Care (Engl). 2022 Jan;31(1):e13529. doi: 10.1111/ecc.13529. Epub 2021 Oct 17.
Insight into the management of cancer in the primary care setting is pivotal to improve early recognition and survival of cancer patients. Therefore, the Netherlands Cancer Registry (NCR) was linked to the General Practitioner (GP) Database of the PHARMO Database Network to make this research possible.
The NCR collects tumour data on all newly diagnosed cancer patients, whereas the GP Database comprises data from electronic patient records registered by GPs. Databases were linked using a probabilistic record linkage technology.
Through record linkage of the NCR and the GP Database, we have established a large population-based cohort (NCR-PHARMO GP cohort) of 135,868 cancer patients. Data are available on demographics, tumour characteristics, primary health care use before and after cancer diagnosis including medication use, medical conditions, laboratory tests, and referrals. Data can be used for a number of different studies, for example, to study the diagnostic pathway in the primary care setting in order to identify possibilities for early recognition.
The NCR-PHARMO GP cohort provides rich data on the primary care management of cancer facilitating large-scale observational cancer research in the primary care setting. The patient-level linkage allows for long-term follow-up of cancer patients, with ongoing annual updates.
深入了解初级保健环境中的癌症管理对于提高癌症患者的早期识别和生存率至关重要。因此,荷兰癌症登记处(NCR)与 PHARMO 数据库网络的全科医生数据库(GP Database)进行了链接,从而实现了这项研究。
NCR 收集所有新诊断癌症患者的肿瘤数据,而 GP Database 则包含全科医生注册的电子患者记录中的数据。使用概率记录链接技术对数据库进行链接。
通过 NCR 和 GP Database 的记录链接,我们建立了一个基于人群的大型队列(NCR-PHARMO GP 队列),其中包括 135,868 名癌症患者。数据包括人口统计学、肿瘤特征、癌症诊断前后的初级保健使用情况,包括用药情况、医疗状况、实验室检查和转诊情况。这些数据可用于多项不同的研究,例如,研究初级保健环境中的诊断途径,以确定早期识别的可能性。
NCR-PHARMO GP 队列提供了有关癌症初级保健管理的丰富数据,为初级保健环境中的大规模观察性癌症研究提供了便利。患者级别的链接允许对癌症患者进行长期随访,并进行持续的年度更新。